Brief: Greenfern Industries Says Greenfern Eyes FDA Approved Cannabinoid Medicine Opportunity

Greenfern Industries

26/08/2022 11:20

Aug 26 (Reuters) - Greenfern Industries Ltd  GFI.NZ :
    * GREENFERN EYES FDA APPROVED CANNABINOID MEDICINE
OPPORTUNIT
    * ENTERED INTO NON-BINDING TERM SHEET WITH AUSTRALIAN-BASED
CANNVALATE PTY LTD
    * GFI WILL BE REQUIRED TO PAY NZ$5M TO CANNVALATE IN RESPECT
OF
SYNDROS LICENCE AND DISTRIBUTION RIGHTS
    * UNDER NON-BINDING TERM SHEET, CANNVALATE WILL INCORPORATE
NEW
ENTITY,  NEWCO, WITH NEWCO TO THEN BE ACQUIRED BY GFI

Source text for Eikon:  ID: 
Further company coverage:  GFI.NZ